Radiolabelled monoclonal antibodies recognizing CD20 or CD37 surface markers on B-cells data

Antibodies provided by IDPH, Bristol-Myers, and Coulter were tested as vehicles for delivery of high doses of radiation to tumors in a patient population that is typically unresponsive.

According to the report in the New England Journal of Medicine, complete responses were achieved in 16 of 19 patients, with nine patients remaining in complete remission for three to more than 53 months. ...